Standard Operating Procedure (SOP): Clinical Management of Endometriosis

This Standard Operating Procedure (SOP) outlines the clinical and administrative framework for the assessment, diagnosis, and management of patients presenting with suspected or confirmed endometriosis. The objective is to standardize the patient journey—from initial screening to long-term chronic disease management—ensuring clinical excellence, evidence-based intervention, and improved quality of life for the patient.

Phase 1: Intake and Initial Assessment

• Medical History Review: Document age of menarche, cycle regularity, duration of menses, and severity of dysmenorrhea using a standardized pain scale (0-10).
• Symptom Mapping: Evaluate for chronic pelvic pain, dyspareunia (painful intercourse), dyschezia (painful defecation), and cyclic bladder pain.
• Physical Examination: Perform a bimanual pelvic exam to assess for uterine mobility, adnexal tenderness, or nodularity in the posterior cul-de-sac.
• Documentation: Utilize the patient electronic health record (EHR) to log pain scores across the cycle phases.

Phase 2: Diagnostic Workup

• Imaging Protocol: Order a specialized pelvic ultrasound (TVUS) focusing on "soft markers" (e.g., ovarian sliding sign).
• Advanced Imaging (If Indicated): Request MRI of the pelvis with endometriosis-specific protocol if deep infiltrating endometriosis (DIE) is suspected.
• Lab Screening: Order baseline tests to rule out comorbid conditions, including PCOS, pelvic inflammatory disease (PID), or irritable bowel syndrome (IBS).
• Referral: If complex anatomical involvement is suspected (e.g., bowel, bladder, or diaphragm), coordinate an immediate referral to a fellowship-trained excision specialist.

Phase 3: Treatment Planning and Management

• Medical Management (First-line): Initiate hormonal suppression therapy (e.g., Combined Oral Contraceptives, Progestins, or GnRH antagonists) based on patient reproductive goals.
• Non-Hormonal Support: Refer to Pelvic Floor Physical Therapy (PFPT) to address muscular pelvic floor dysfunction and chronic guarding.
• Surgical Intervention: Discuss laparoscopic excision surgery if medical management fails or if infertility is the primary concern.
• Counseling: Provide a clear summary of surgical risks (adhesions, recurrence) vs. benefits (pain relief, improved fertility).

Phase 4: Follow-Up and Long-Term Care

• Scheduled Review: Assess efficacy of hormonal intervention at the 3-month mark.
• Pain Management Audit: Review patient pain journals and adjust medication dosages as necessary.
• Multidisciplinary Check-in: Coordinate with nutritionists or pain management psychologists for holistic care integration.

Pro Tips & Pitfalls

• Pro Tip: Always utilize a multidisciplinary approach. Endometriosis is a systemic disease, not just a gynecological one; engage physical therapists and pain specialists early.
• Pro Tip: Document "negative" findings clearly. If a pelvic exam is normal, it does not rule out endometriosis; document that "normal anatomy does not preclude disease."
• Pitfall: Avoid the "wait and see" approach for adolescents with severe dysmenorrhea. Early intervention can prevent the progression of disease and the development of centralized pain pathways.
• Pitfall: Do not assume ultrasound is the gold standard. A "normal" ultrasound result is common even in cases of severe peritoneal endometriosis.

Frequently Asked Questions (FAQ)

1. If the ultrasound is normal, does the patient have endometriosis? No. Ultrasound is excellent for identifying endometriomas (cysts) and deep infiltrating disease, but it is often unable to detect superficial peritoneal implants. Diagnosis is confirmed through clinical suspicion or laparoscopic visualization.

2. Is surgery the only way to treat endometriosis? No. Surgery is one pillar of treatment. Hormonal suppression, pelvic floor physical therapy, anti-inflammatory dietary changes, and stress management are all essential components of a multi-modal treatment plan.

3. How often should patients be monitored after starting hormonal therapy? Initial follow-up should occur at 8–12 weeks to assess for side effects and medication tolerability. Thereafter, if the condition is stable, check-ups should occur every 6–12 months to monitor long-term health and symptom control.